5:09 PM
Jan 23, 2012
 |  BC Extra  |  Clinical News

CHMP adopts opinion on AD biomarker

EMA's CHMP adopted a final qualification opinion that low hippocampal volume is predictive of Alzheimer's disease-type dementia in patients with cognitive impairment. The MRI-detected biomarker can now be used...

Read the full 126 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >